HAE
Haemonetics Corporation
Medical Devices · Healthcare · United States
90.38
close · 2026-08-13
value
59
cheaper than peers59
quality
58
stronger fundamentals58
ranked against
Medical Devices
value
quality
55 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 15.75× | 76 |
| EV to EBITDA | 13.79× | 68 |
| price to sales | 2.91× | 49 |
| price to book | 4.91× | 41 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 17.9% | 85 |
| return on equity | 11.2% | 73 |
| revenue growth | 5.6% | 37 |
| debt to equity | 140.3% | 25 |
4 of 4 measures available
Facts
| market cap | $4B |
| free cash flow | $312.8M |
| employees | 3,009 |
| first trade | 1991-05-10 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-10 |